CACNA1H-associated epilepsy has demonstrated responsiveness to lamotrigine or ethosuximide therapy.9,41 In our cohort, children with variants in these genes have at least weekly seizures, have failed three or more ASMs to control their seizures, and had not yet trialed possible precision medicine therapies. This evidence concerns the gene CACNA1H and epilepsy.